| Article ID | Journal | Published Year | Pages | File Type | 
|---|---|---|---|---|
| 7512282 | International Journal of Drug Policy | 2018 | 9 Pages | 
Abstract
												For the first time, this study offers a rich detail of attitudes toward 2,4-DNP use by giving a collective voice to users. The element of control over every aspect of the users' life appears to be a significant contributor to the successful risk-management of 2,4-DNP use. In the absence of an established safe upper limit and effective regulatory control, education is critical to harm minimisation.
											Related Topics
												
													Health Sciences
													Medicine and Dentistry
													Psychiatry and Mental Health
												
											Authors
												Neha Prasad Ainsworth, Elisabeth Julie Vargo, Andrea Petróczi, 
											